Therapeutic Area | MeSH |
---|---|
nervous system diseases | D009422 |
mental disorders | D001523 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADDERALL XR 10 | Takeda | N-021303 RX | 2001-10-11 | 1 products, RLD |
ADDERALL XR 20 | Takeda | N-021303 RX | 2001-10-11 | 1 products, RLD |
ADDERALL XR 30 | Takeda | N-021303 RX | 2001-10-11 | 1 products, RLD, RS |
ADDERALL XR 25 | Takeda | N-021303 RX | 2002-05-22 | 1 products, RLD |
ADDERALL XR 5 | Takeda | N-021303 RX | 2002-05-22 | 1 products, RLD |
ADDERALL XR 15 | Takeda | N-021303 RX | 2002-05-22 | 1 products, RLD |
MYDAYIS | Takeda | N-022063 RX | 2017-06-20 | 4 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DEXEDRINE SPANSULE | Impax Laboratories | N-017078 RX | 1982-01-01 | 3 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DYANAVEL XR | Tris Pharma | N-208147 RX | 2015-10-19 | 1 products, RLD, RS |
DYANAVEL XR 5 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD |
DYANAVEL XR 10 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD |
DYANAVEL XR 15 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD |
DYANAVEL XR 20 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XELSTRYM | Noven Pharmaceuticals | N-215401 RX | 2022-03-22 | 4 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
adderall | New Drug Application | 2025-03-13 |
adderall xr | New Drug Application | 2010-03-29 |
dexedrine | New Drug Application | 2023-10-23 |
dextroamphetamine | ANDA | 2025-03-26 |
dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate | ANDA | 2023-10-20 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | ANDA | 2025-03-17 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate | ANDA | 2024-02-05 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release | ANDA | 2024-02-01 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | ANDA | 2024-12-27 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release | ANDA | 2024-01-12 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
narcolepsy | EFO_0000614 | D009290 | G47.4 |
attention deficit disorder with hyperactivity | EFO_0003888 | D001289 | F90 |
Expiration | Code | ||
---|---|---|---|
DEXTROAMPHETAMINE, XELSTRYM, NOVEN PHARMS INC | |||
2025-03-22 | NP | ||
AMPHETAMINE ASPARTATE / AMPHETAMINE SULFATE / DEXTROAMPHETAMINE SACCHARATE / DEXTROAMPHETAMINE SULFATE, MYDAYIS, TAKEDA PHARMS USA | |||
2023-03-13 | PED |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Dextroamphetamine, Xelstrym, Noven Pharms Inc | |||
11559501 | 2042-01-06 | DP | |
9456993 | 2033-10-24 | DP | U-3340 |
9474722 | 2033-10-24 | DP | |
8591941 | 2025-10-07 | DP | |
8632802 | 2025-10-07 | DP | |
9034370 | 2025-10-07 | DP | |
Amphetamine Aspartate / Amphetamine Sulfate / Dextroamphetamine Saccharate / Dextroamphetamine Sulfate, Mydayis, Takeda Pharms Usa | |||
8846100 | 2029-08-24 | DP | |
9173857 | 2026-05-12 | U-2025 | |
6913768 | 2023-05-24 | DP | U-2025 |
Code | Description |
---|---|
S0160 | Dextroamphetamine sulfate, 5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | — | 1 | — | — | — | 1 |
Drug common name | Dextroamphetamine |
INN | dexamfetamine |
Description | (S)-amphetamine is a 1-phenylpropan-2-amine that has S configuration. It has a role as a neurotoxin, an adrenergic uptake inhibitor, a dopaminergic agent, a sympathomimetic agent, a dopamine uptake inhibitor and an adrenergic agent. It is an enantiomer of a (R)-amphetamine. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H](N)Cc1ccccc1 |
PDB | — |
CAS-ID | 51-64-9 |
RxCUI | — |
ChEMBL ID | CHEMBL612 |
ChEBI ID | 4469 |
PubChem CID | 5826 |
DrugBank | DB01576 |
UNII ID | TZ47U051FI (ChemIDplus, GSRS) |